Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.5%

1 terminated out of 66 trials

Success Rate

96.2%

+9.7% vs benchmark

Late-Stage Pipeline

11%

7 trials in Phase 3/4

Results Transparency

4%

1 of 25 completed with results

Key Signals

1 with results96% success

Data Visualizations

Phase Distribution

46Total
Not Applicable (33)
P 1 (1)
P 2 (5)
P 4 (7)

Trial Status

Completed25
Unknown17
Recruiting14
Active Not Recruiting5
Not Yet Recruiting4
Terminated1

Trial Success Rate

96.2%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (66)

Showing 20 of 20 trials
NCT05915286Phase 4TerminatedPrimary

Diuretic Use in Hemodialysis Patients With Residual Renal Function

NCT04603014Phase 2Active Not RecruitingPrimary

Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients

NCT05735743Not ApplicableActive Not RecruitingPrimary

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

NCT07538687Not ApplicableNot Yet RecruitingPrimary

VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery

NCT07425262Phase 2Not Yet RecruitingPrimary

A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension

NCT06042153Phase 4Active Not Recruiting

DIALYSIS-TIR Study

NCT05654103Not ApplicableRecruitingPrimary

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

NCT05159999Not ApplicableActive Not RecruitingPrimary

The Home Blood Pressure (BP) Trial

NCT06526702Not ApplicableCompletedPrimary

Intradialytic Kinetics of Cardiac Biomarkers During Hemodialysis and Hemodiafiltration

NCT07014111Not ApplicableRecruitingPrimary

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

NCT07141641Unknown

Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access

NCT07130721Not Yet RecruitingPrimary

Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

NCT07111260Not ApplicableRecruitingPrimary

Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)

NCT06483074Phase 2RecruitingPrimary

Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

NCT07086430Completed

Independent Effects of Visceral Adipose Volume and Density on Patient Survival in Peritoneal Dialysis

NCT05846581Recruiting

Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access

NCT07053462Phase 1Recruiting

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

NCT06581393Not ApplicableCompleted

First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings

NCT07016841RecruitingPrimary

Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins

NCT05540457Not ApplicableCompleted

Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)

Scroll to load more

Research Network

Activity Timeline